T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.

Bonham CA, Hrusch CL, Blaine KM, Manns ST, Vij R, Oldham JM, Churpek MM, Strek ME, Noth I, Sperling AI

Open source

DOI
10.1016/j.yrmex.2019.100002
Published
2019
Container
Respiratory medicine: X
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.yrmex.2019.100002,
  title = {T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.},
  author = {Bonham CA and Hrusch CL and Blaine KM and Manns ST and Vij R and Oldham JM and Churpek MM and Strek ME and Noth I and Sperling AI},
  year = {2019},
  journal = {Respiratory medicine: X},
  doi = {10.1016/j.yrmex.2019.100002},
  url = {https://doi.org/10.1016/j.yrmex.2019.100002}
}

RIS

TY  - JOUR
TI  - T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.
AU  - Bonham CA
AU  - Hrusch CL
AU  - Blaine KM
AU  - Manns ST
AU  - Vij R
AU  - Oldham JM
AU  - Churpek MM
AU  - Strek ME
AU  - Noth I
AU  - Sperling AI
PY  - 2019
JO  - Respiratory medicine: X
DO  - 10.1016/j.yrmex.2019.100002
UR  - https://doi.org/10.1016/j.yrmex.2019.100002
ER  - 

APA

CA, B., CL, H., KM, B., ST, M., R, V., JM, O., MM, C., ME, S., I, N., & AI, S. (2019). T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.. Respiratory medicine: X. https://doi.org/10.1016/j.yrmex.2019.100002

Source records